Shares of Livongo Health (NASDAQ:LVGO) rose 8.1% during mid-day trading on Friday . The stock traded as high as $37.04 and last traded at $36.79, approximately 406,833 shares traded hands during trading. A decline of 59% from the average daily volume of 986,656 shares. The stock had previously closed at $34.03.
Separately, Chardan Capital initiated coverage on Livongo Health in a report on Friday. They set a “neutral” rating and a $40.00 price objective on the stock.
In other Livongo Health news, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of the company’s stock in a transaction on Monday, July 29th. The shares were bought at an average cost of $28.00 per share, for a total transaction of $87,970,260.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Hemant Taneja acquired 2,678,571 shares of the company’s stock in a transaction on Monday, July 29th. The shares were acquired at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The disclosure for this purchase can be found here.
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Featured Story: Green Investing
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.